Inventor

RETTIG WOLFGANG J

DE19 patents

⚠️ This page may combine multiple inventors who share the name “RETTIG WOLFGANG J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RETTIG WOLFGANG J

LUDWIG INST CANCER RES

Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof

Method for treating cancers which present antigen FB5 with humanized antibodies

Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigen

Method for detecting cancers

Recombinant human anti-FB5 antibodies

Tumor rejection antigen precursor

Recombinant humanized anti-FB5 antibodies

Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1

SLOAN KETTERING INST CANCER

Recombinant human anti-LK26 antibodies

Choriocarcinoma monoclonal antibodies and antibody panels

Method for treating cancers

Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof

Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium

Cell-surface glycoproteins of human sarcomas

Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells

Isolated antigen endo glyx-1

BOEHRINGER INGELHEIM INT

FAPα-specific antibody with improved producibility

SLOAN KETTERING CANCER CENTER

Recombinant human anti-LK26 antibodies

BOEHRINGER INGELHEIM PHARMA

FAP-activated anti-tumour compounds